Device Trial Radar · NCT07390344
VIATORR® TIPS Study Evaluating 6-10mm Diameters (VIATIPS)
Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
152
Planned (sponsor's estimate)
Start
Jul 20, 2026
Primary completion
Sep 30, 2029
Study completion Sep 30, 2029
Sponsor
- Lead sponsor
- W.L.Gore & AssociatesNot on our public-company list
- Sponsor type
- Industry
- First posted
- Feb 5, 2026
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This Registry will look at patients being treated with a transjugular intrahepatic portosystemic shunt (TIPS) procedure for portal hypertension. The purpose of this Registry is to collect data on the safety and performance of the GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion (6-10mm) for 2 years in real world setting. Additionally, data will be collected on the safety and performance of the GORE TIPS Set when utilized.
Conditions
- Ascites
- Variceal Bleeding
- Portal Hypertension Related to Cirrhosis
Interventions
GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion (6-10mm)Device
The GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion (6-10mm) was developed and approved for the treatment of portal hypertension and its complications such as bleeding from enlarged or swollen veins (variceal bleeding) and abnormal build-up of fluid in the abdomen that does not respond to therapy (ascites which recurs despite conventional treatment). The Registry Device is a small tube (stent) that creates a pathway for blood flow. It consists of a metal frame (nitinol), covered with a thin, flexible material called expandable polytetrafluoroethylene (ePTFE).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Subjects achieving primary patency through 2 yearsTime frame: Shunt primary patency will be analyzed at 1, 3, 6, 12 and 24 months.
Locations
5 sites in 2 countries. Site status is shown where the registry gives one.
Emory University Hospital
Atlanta, Georgia · Recruiting
University of Minnesota
Minneapolis, Minnesota · Recruiting
Cleveland Clinic
Cleveland, Ohio · Recruiting
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.